{"denoms":[{"counts":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"18"}],"units":"Participants"}],"groups":[{"description":"treatment: 1.3 mg/m\\^2","id":"BG000","title":"Bortezomib, Cohort a"},{"description":"treatment: 1.0 mg/m\\^2","id":"BG001","title":"Bortezomib, Cohort b"},{"description":"treatment: 0.7 mg/m\\^2","id":"BG002","title":"Bortezomib, Cohort c"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"<=18 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"3"},{"groupId":"BG003","value":"9"}]}],"title":"Between 18 and 65 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"5"},{"groupId":"BG003","value":"9"}]}],"title":">=65 years"}],"paramType":"NUMBER","title":"Age Categorical","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.78","value":"65"},{"groupId":"BG001","spread":"8.69","value":"70.75"},{"groupId":"BG003","spread":"8.98","value":"67.55"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"4"},{"groupId":"BG003","value":"9"}]}],"title":"Female"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"4"},{"groupId":"BG003","value":"9"}]}],"title":"Male"}],"paramType":"NUMBER","title":"Gender","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"8"},{"groupId":"BG003","value":"18"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}